Here’s ET NOW in exclusive conversation with none other than Dilip Shangvi - MD of Sun Pharma who has just taken a troubled Ranbaxy under his wings. The Gurgaon-based drug maker Ranbaxy cost Shangvi as much as $4 billion - the biggest deal in Indian pharma. Can Shangvi pull his wizardry to revive Ranbaxy, which finds itself cornered by a host of issues? We started off by asking Shangvi his prescription to revive Ranbaxy! Take it away.
